(Q43857194)

27 November 2017

title

A new warfarin dosing algorithm including VKORC1 3730 G > A polymorphism: comparison with results obtained by other published algorithms (English)

1 reference

27 November 2017

0 references

1 reference

Michela Cini

1

0 references

Cristina Legnani

object named as

Cristina Legnani

2

0 references

Gualtiero Palareti

7

object named as

Gualtiero Palareti

1 reference

27 November 2017

Benilde Cosmi

3

1 reference

27 November 2017

Giuliana Guazzaloca

4

1 reference

27 November 2017

Lelia Valdrè

5

1 reference

27 November 2017

Mirella Frascaro

6

1 reference

27 November 2017

publication date

19 February 2012

1 reference

European Journal of Clinical Pharmacology

27 November 2017

published in

1 reference

27 November 2017

volume

68

1 reference

27 November 2017

issue

8

1 reference

27 November 2017

page(s)

1167-1174

1 reference

Role of warfarin pharmacogenetic testing in clinical practice

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1226-5

21 January 2018

Predicting warfarin dose

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1226-5

Warfarin-dosing algorithm based on a population pharmacokinetic/pharmacodynamic model combined with Bayesian forecasting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1226-5

21 January 2018

Oral anticoagulant drugs

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1226-5

Integration of genetic, clinical, and INR data to refine warfarin dosing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1226-5

Validation and comparison of pharmacogenetics-based warfarin dosing algorithms for application of pharmacogenetic testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1226-5

Evidence for a pharmacogenetic adapted dose of oral anticoagulant in routine medical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1226-5

Interactions of warfarin with drugs and food

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1226-5

Randomized trial of genotype-guided versus standard warfarin dosing in patients initiating oral anticoagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1226-5

Pharmacogenetics of warfarin: regulatory, scientific, and clinical issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1226-5

Estimation of the warfarin dose with clinical and pharmacogenetic data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1226-5

Pharmacogenetics of warfarin: development of a dosing algorithm for brazilian patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1226-5

The impact of CYP2C9 and VKORC1 genetic polymorphism and patient characteristics upon warfarin dose requirements: proposal for a new dosing regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1226-5

Dosing algorithms to predict warfarin maintenance dose in Caucasians and African Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1226-5

The largest prospective warfarin-treated cohort supports genetic forecasting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1226-5

VKORC1, CYP2C9 and CYP4F2 genetic-based algorithm for warfarin dosing: an Italian retrospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1226-5

Patient-specific factors predictive of warfarin dosage requirements

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1226-5

Less benefit from warfarin in diabetics after myocardial infarction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1226-5

Efficacy of long-term anticoagulant treatment in subgroups of patients after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1226-5

Optimization of warfarin dose by population-specific pharmacogenomic algorithm.

21 January 2018

1 reference

12 December 2020

VKORCI haplotypes and their impact on the inter-individual and inter-ethnical variability of oral anticoagulation

1 reference

12 December 2020

Warfarin pharmacogenetics

1 reference

12 December 2020

Gamma-glutamyl carboxylase (GGCX) tagSNPs have limited utility for predicting warfarin maintenance dose

1 reference

12 December 2020

Estimation of warfarin maintenance dose based on VKORC1 (-1639 G>A) and CYP2C9 genotypes

1 reference

12 December 2020

Effects of long-term anticoagulant therapy in subgroups after acute myocardial infarction

1 reference

12 December 2020

10.1007/S00228-012-1226-5

Identifiers

DOI

1 reference

27 November 2017

1 reference